Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | F9 | P00740 | 1/20 | 0.37 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | MAPT | P10636 | 1/20 | 0.35 |
| ▸ | HPGD | P15428 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GPR3 | P46089 | 1/20 | 0.33 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.33 |
| ▸ | CYP1B1 | Q16678 | 1/20 | 0.33 |
| ▸ | ABCB1 | P08183 | 1/20 | 0.31 |
| ▸ | GPR84 | Q9NQS5 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23790520 | 1.00 | F9 (0.37) | F9ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL23790504 | 0.90 | F9 (0.34) | F9ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL23790368 | 0.90 | F9 (0.34) | F9ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL23790544 | 0.88 | ALDH1A1 (0.39) | F9ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL23790688 | 0.88 | ALDH1A1 (0.39) | F9ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL22452129 | 0.86 | ALDH1A1 (0.38) | F9ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL25578734 | 0.86 | F9 (0.38) | F9ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL20441897 | 0.86 | F9 (0.34) | F9ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL19660483 | 0.85 | ALDH1A1 (0.39) | F9ALDH1A1MAPTHPGDRAB9A | |
| SCHEMBL24472318 | 0.85 | MAPT (0.41) | F9ALDH1A1MAPTHPGDRAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20210280786-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND DIAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | SAMSUNG DISPLAY CO., LTD. (KR) | 2021-09-09 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210280786-A1 | ORGANIC ELECTROLUMINESCENCE DEVICE AND DIAMINE COMPOUND FOR ORGANIC ELECTROLUMINESCENCE DEVICE | AOC1, ODC1, SAT1 | F9 3425/4885ALDH1A1 32/4885MAPT 1427/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.